$MCRB Stock Is up 24% Today. Here's What We See in Our Data.
Seres Therapeutics to Announce First Quarter 2025 Financial Results and Business Updates on May 7, 2025
Quest Diagnostics Posts Better-Than-Expected Earnings, Joins Pentair, 3M, Danaher And Other Big Stocks Moving Higher On Tuesday
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Seres Therapeutics Trading Halted, News Pending
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Seres Therapeutics To Carry Out 1-for-20 Reverse Stock Split On April 22nd, 2025
12 Health Care Stocks Moving In Monday's After-Market Session
Seres Therapeutics Approves Reverse Stock Split Plan
Seres Therapeutics Price Target Maintained With a $1.25/Share by Chardan Capital
Seres Therapeutics Is Maintained at Buy by Chardan Capital
Piper Sandler Downgrades Seres Therapeutics(MCRB.US) to Hold Rating, Cuts Target Price to $1
Express News | Goldman Sachs Maintains Sell on Seres Therapeutics, Lowers Price Target to $0.75
Seres Therapeutics Analyst Ratings
Seres Therapeutics, Inc. (NASDAQ:MCRB): Are Analysts Optimistic?
Seres Therapeutics (MCRB) Gets a Hold From Piper Sandler
TD Cowen Maintains Seres Therapeutics(MCRB.US) With Buy Rating
Seres Therapeutics Earnings Call: Progress Amid Uncertainty
Seres Therapeutics: Strategic Developments and Promising Clinical Data Justify Buy Rating
Seres Therapeutics | 10-K: FY2024 Annual Report